BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12090340)

  • 1. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.
    Bozlu M; Orhan D; Baltaci S; Yaman O; Elhan AH; Tulunay O; Müftüoğlu YZ
    Int Urol Nephrol; 2002; 33(1):59-66. PubMed ID: 12090340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
    Krüger S; Müller H
    Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic importance of the nucleolar organizer region (AgNOR), Ki-67 and proliferating cell nuclear antigen (PCNA) in primary nonurachal bladder adenocarcinoma.
    Ozdemir BH; Ozdemir OG; Sertçelik A
    APMIS; 2001 Jun; 109(6):428-34. PubMed ID: 11506474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
    Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
    J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters.
    Skopelitou A; Korkolopoulou P; Papanicolaou A; Christodoulou P; Thomas-Tsagli E; Pavlakis K
    Eur Urol; 1992; 22(3):235-40. PubMed ID: 1361436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of mitotic indices, AgNor count, Ki-67 and Bcl-2 with grade and stage in papillary urothelial bladder cancer.
    Goyal S; Singh UR; Sharma S; Kaur N
    Urol J; 2014 Mar; 11(1):1238-47. PubMed ID: 24595931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferating cell nuclear antigen cyclin in human transitional cell carcinoma.
    Hattori K; Uchida K; Akaza H; Koiso K; Nemoto R; Harada M
    Br J Urol; 1995 Feb; 75(2):162-6. PubMed ID: 7850319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
    Brustmann H; Naudé S
    Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 scores and AgNor counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value.
    Zambelli S; Zanin A; Gaglio A; Zai G; Bosco E; Andrion A; Magnani C
    Arch Ital Urol Androl; 1993 Dec; 65(6):665-70. PubMed ID: 8312949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
    Delahunt B; Bethwaite PB; Thornton A; Ribas JL
    Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
    Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
    Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AgNOR count in resting cells (resting NOR) is a new prognostic marker in invasive bladder tumor.
    Tomobe M; Shimazui T; Uchida K; Akaza H
    Anal Cell Pathol; 2001; 22(4):193-9. PubMed ID: 11564895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
    Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p120 and AgNOR nucleolar protein expression: a comparison with nuclear proliferation markers in oral pathology.
    Migaldi M; Criscuolo M; Zunarelli E; Lo Bianco L; Martinelli AM; Barbolini G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Feb; 85(2):189-96. PubMed ID: 9503455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
    Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
    J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
    Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
    Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA.
    Löhr CV; Teifke JP; Failing K; Weiss E
    Vet Pathol; 1997 May; 34(3):212-21. PubMed ID: 9163877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.